In The News

CDC Expands Recommendations for Use of Bivalent COVID-19 Booster

Last Wednesday, the CDC expanded recommendations for the use of Pfizer-BioNTech COVID-19 bivalent vaccine for ages 5 through 11 years old and Moderna COVID-19 bivalent vaccine for ages 6 through 17 years old. The “updated boosters” vaccines target multiple strains of COVID-19—the original strain of the virus and 2 of the Omicron variants (BA.4 and BA.5).

The updated boost doses for this age group are already available for those seeking Moderna and arriving this week for Pfizer. Various providers will be offering the bivalent boost dose for this age group including local pharmacies, doctor’s offices and health departments.
 
Individuals may choose to receive either the Moderna or Pfizer bivalent booster, regardless of which primary series vaccine or original booster dose they received. The current monovalent vaccine is no longer available for those 5 and older for use as a booster but remains available to complete the primary series.

Those who are eligible to receive a bivalent booster dose right now include:

  • Moderna Booster: Individuals 6 years of age and older if it has been at least 2 months since they completed their primary vaccination series or received a booster dose.
  • Pfizer-BioNTech: Individuals 5 years of age and older if it has been at least 2 months since they completed their primary vaccination series or received a booster dose.
 

Home and Community-Based Services (HCBS) Webpage

HCBS Waivers provide opportunities for Medicaid beneficiaries to receive select long-term care services in their own home or community rather than institutions or other isolated settings. These programs serve a variety of targeted populations, such as people with intellectual or developmental disabilities, physical disabilities, and/or mental illnesses. Colorado offers a wide array of waiver programs with the goal of serving Coloradans in their preferred location. Offering robust waiver options supports the United States Supreme Court Olmstead v. L.C. decision which says that unjustified segregation of persons with disabilities constitutes discrimination in violation of title II of the Americans with Disabilities Act.

What is an HCBC Waiver?

An HCBS waiver program allows the state to waive some Medicaid requirements to meet the needs of individual populations. For example, a waiver program may help a member access in-home personal care, assist the member with making meals, or provide rides to doctor appointments or community activities. To access a waiver, a member must meet a level-of-care requirement unique to the waiver program for which they are applying. HCBS waivers provide a person with individualized care starting with the person-centered support plan. HCBS waivers have unique program rules. An HCBS waiver program may have a waitlist. Currently, Colorado offers ten (10) HCBS waivers.

About the HCBS Waivers webpage

This webpage includes the following areas of information:

  • Waiver comparison charts for adult HCBS programs and children’s HCBS programs
  • Waiver documents and lifecycle
  • Links to individual waiver pages which detail:
  • Eligible populations
  • Benefits and services provided
  • How to make an application
  • Other useful links
  • Public Comment Opportunities

We hope you'll bookmark the HCBS waivers page and share this resource with your organizations and networks.

 

Management Redesign (CMRD) Rule Revision Stakeholder Feedback Meeting Series

The Department will update rules and regulations pertaining to HCBS waivers and non-waiver programs to come into alignment with new CMRD statute, policy, and language. Rule updates are required to clean up areas in existing rule and waivers that are repetitious, obsolete, or difficult to follow and understand. CMRD also implements changes to the rule structure. The vision behind the structure change is to make the HCBS rules easier to find, read and understand for all stakeholders. Rules must be in effect no later than Nov. 1, 2023, at which point the first cohort of new Case Management Agencies under CMRD will transition.

The Department wants to hear from stakeholders about each of the rule revision topics listed below to ask questions and receive feedback based on your knowledge and experience with navigating HCBS rules. The goals is to make these rule revisions work for all HCBS stakeholders. The Department will post the section of rule or waiver to be discussed on the CMRD webpage one week prior to each meeting. Stakeholder engagement, feedback, and Department responses will be tracked through listening logs posted on the CMRD webpage.

Note: The 2022 meetings below are posted on the OCL Stakeholder Engagement Calendar. You can copy them from the calendar to your individual calendar from there. The 2023 meetings below will be posted on the OCL calendar before the end of December 2022.

 

The meeting access information for all the CMRD meetings is the same:

Join via Zoom

Meeting ID: 873 9014 4539, Passcode: 597847

Join via Phone: Toll-free: 1-877 853 5257

 

Tuesday Oct. 25, 2022 (9-11 a.m. MT)

This is a kick-off meeting with explanation of CMRD and HCBS rule making process, including stakeholder feedback and responses from the Department.

Tuesday Nov. 8, 2022 (9-11 a.m. MT)

HCBS Waiver Amendments and Applications. This meeting provides explanation & review of the 1915b4 waiver application as it relates to CMRD, including stakeholder feedback and responses from the Department.

Tuesday Nov. 22, 2022 (9-11 a.m. MT)

HCBS Waiver Program Eligibility Rules. This meeting provides explanation & review of changes/updates to the HCBS waiver program eligibility rules as it relates to CMRD, including stakeholder feedback and responses from the Department.

Tuesday Dec. 6, 2022 (9-11 a.m. MT) 

HCBS Waiver Program Eligibility Rules, Part Two. This meeting provides explanation and review of changes/updates to the HCBS waiver program eligibility rules as it relates to CMRD, this is part 2 and the conclusion to the HCBS waiver program eligibility rules, including stakeholder feedback and responses from the Department.

Tuesday Dec. 20, 2022 (9-11 a.m. MT)

Case Management Agency Requirements. This meeting provides explanation and review of changes/updates to the Case Management Agency’s requirements rules as it relates to CMRD, including stakeholder feedback and responses from the Department.

 

‘The Cash Monster Was Insatiable’: How Insurers Exploited Medicare for Billions

The New York Times | By Reed Abelson and Margot Sanger-Katz

By next year, half of Medicare beneficiaries will have a private Medicare Advantage plan. Most large insurers in the program have been accused in court of fraud.

The health system Kaiser Permanente called doctors in during lunch and after work and urged them to add additional illnesses to the medical records of patients they hadn’t seen in weeks. Doctors who found enough new diagnoses could earn bottles of Champagne, or a bonus in their paycheck.

Anthem, a large insurer now called Elevance Health, paid more to doctors who said their patients were sicker. And executives at UnitedHealth Group, the country’s largest insurer, told their workers to mine old medical records for more illnesses — and when they couldn’t find enough, sent them back to try again.

Each of the strategies — which were described by the Justice Department in lawsuits against the companies — led to diagnoses of serious diseases that might have never existed. But the diagnoses had a lucrative side effect: They let the insurers collect more money from the federal government’s Medicare Advantage program.

Medicare Advantage, a private-sector alternative to traditional Medicare, was designed by Congress two decades ago to encourage health insurers to find innovative ways to provide better care at lower cost. If trends hold, by next year, more than half of Medicare recipients will be in a private plan.

But a New York Times review of dozens of fraud lawsuits, inspector general audits and investigations by watchdogs shows how major health insurers exploited the program to inflate their profits by billions of dollars.

The government pays Medicare Advantage insurers a set amount for each person who enrolls, with higher rates for sicker patients. And the insurers, among the largest and most prosperous American companies, have developed elaborate systems to make their patients appear as sick as possible, often without providing additional treatment, according to the lawsuits.

As a result, a program devised to help lower health care spending has instead become substantially more costly than the traditional government program it was meant to improve.

Eight of the 10 biggest Medicare Advantage insurers — representing more than two-thirds of the market — have submitted inflated bills, according to the federal audits. And four of the five largest players — UnitedHealth, Humana, Elevance and Kaiser — have faced federal lawsuits alleging that efforts to overdiagnose their customers crossed the line into fraud.

The fifth company, CVS Health, which owns Aetna, told investors its practices were being investigated by the Department of Justice.

In statements, most of the insurers disputed the allegations in the lawsuits and said the federal audits were flawed. They said their aim in documenting more conditions was to improve care by accurately describing their patients’ health.

Read Full Article

 

BPC Recommends Two-Year Extension Of Pandemic-Era Telehealth Policies

Inside Health Policy | By Jessica Karins
  
The Bipartisan Policy Center has released a wide-ranging slate of recommendations for telehealth policy after the COVID-19 public health emergency, including calling for a two-year extension of most telehealth flexibilities, which the group says would offer time for policymakers to further study the most-effective approaches to virtual care.
 
The recommendation could boost efforts by stakeholders to convince the Senate to pass by year’s end the two-year telehealth extension bill that cleared the House.
 
But BPC also calls for Congress to require that HHS and Congress’ Medicare payment advisers study hot-button issues before permanently expanding telehealth.
 
Researchers should use the time to study the benefits of hybrid care and what specialties and conditions it is most effective for, asses the value of audio-only care, and consider how telehealth flexibilities can fit into value-based care models, the report says.
 
In the Oct. 11 report titled “The Future of Telehealth After COVID-19: New Opportunities and Challenges,” the think tank issues numerous recommendations for how policymakers can preserve the benefits of telehealth after the end of the PHE.
 
“For starters, Congress and the Biden administration should extend most of the telehealth flexibilities for Medicare beneficiaries for two years after the end of the PHE, and formally evaluate their impact,” BPC wrote.
 
It says a two-year extension of flexibilities to further study their impact and efficacy would maintain patients’ access to care while minimizing risks.

Read Full Article

 
<< first < Prev 191 192 193 194 195 196 197 198 199 200 Next > last >>

Page 198 of 388